(Q34394777)

1 August 2017

1 reference

title

Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Xunrong L

1

1 reference

1 August 2017

Yan AW

series ordinal

2

1 reference

1 August 2017

Liang R

series ordinal

3

1 reference

1 August 2017

Lau GK

series ordinal

4

1 reference

1 August 2017

1 September 2001

1 reference

Reviews in Medical Virology

1 August 2017

1 reference

1 August 2017

11

1 reference

1 August 2017

5

1 reference

1 August 2017

287-299

1 reference

Chronic hepatitis B virus infection: treatment strategies for the next millennium

1 August 2017

1 reference

Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective

21 January 2018

1 reference

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem

21 January 2018

1 reference

Hepatitis B virus infection in Chinese families in Hong Kong.

21 January 2018

1 reference

Natural and iatrogenic variation in hepatitis B virus

21 January 2018

1 reference

Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia

21 January 2018

1 reference

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

21 January 2018

1 reference

Hepatitis B virus infection in allogeneic bone marrow transplantation

21 January 2018

1 reference

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

21 January 2018

1 reference

Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir

21 January 2018

1 reference

Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy

21 January 2018

1 reference

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

21 January 2018

1 reference

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature

21 January 2018

1 reference

Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma

21 January 2018

1 reference

Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment

21 January 2018

1 reference

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

21 January 2018

1 reference

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment

21 January 2018

1 reference

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc

21 January 2018

1 reference

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

21 January 2018

1 reference

Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus

21 January 2018

1 reference

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

21 January 2018

1 reference

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

21 January 2018

1 reference

Hepatitis B virus DNA contains a glucocorticoid-responsive element

21 January 2018

1 reference

Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells

21 January 2018

1 reference

Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks

21 January 2018

1 reference

Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation.

21 January 2018

1 reference

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.

21 January 2018

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Famciclovir in chronic hepatitis B: results of a dose-finding study

21 January 2018

1 reference

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

21 January 2018

1 reference

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

21 January 2018

1 reference

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

21 January 2018

1 reference

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

21 January 2018

1 reference

Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up

21 January 2018

1 reference

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

21 January 2018

1 reference

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

21 January 2018

1 reference

Hepatitis B infection in patients with lymphomas

21 January 2018

1 reference

Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

21 January 2018

1 reference

C ASE R EPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy

21 January 2018

1 reference

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

Reactivation of hepatitis B virus by corticosteroids in a case of idiopathic nephrotic syndrome

21 January 2018

1 reference

Delayed reactivation of hepatitis B infection after cladribine

21 January 2018

1 reference

Hepatitis B associated liver failure following bone marrow transplantation

21 January 2018

1 reference

Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature

21 January 2018

1 reference

Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC

21 January 2018

1 reference

Reactivation of chronic hepatitis B virus infection.

21 January 2018

1 reference

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

21 January 2018

1 reference

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

21 January 2018

1 reference

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

21 January 2018

1 reference

Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc

21 January 2018

1 reference

Lamivudine as initial treatment for chronic hepatitis B in the United States

21 January 2018

1 reference

A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B

21 January 2018

1 reference

Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy

21 January 2018

1 reference

Lamivudine resistance inimmunocompetent chronic hepatitis B

21 January 2018

1 reference

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.322

1 reference

1 August 2017

1 reference